カテゴリ： 世界, 医療/バイオ, Market Monitor Global

医薬品用OEM＆ODMのグローバル市場展望 2023年-2029年：医薬品OEM、医薬品ODM

■ 英語タイトル：Pharmaceutical OEM and ODM Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC16527）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC16527
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：100
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[医薬品用OEM＆ODMのグローバル市場展望 2023年-2029年：医薬品OEM、医薬品ODM]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の医薬品用OEM＆ODM市場規模と予測を収録しています。・世界の医薬品用OEM＆ODM市場：売上、2018年-2023年、2024年-2029年
・世界の医薬品用OEM＆ODM市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の医薬品用OEM＆ODM市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「医薬品OEM」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

医薬品用OEM＆ODMのグローバル主要企業は、JPS Pharmaceutical、 New-In CO., Ltd.、 Kosei Pharmaceutical Co., Ltd.、 CD Formulation、 DENKEN GROUP、 PIM Pharmaceuticals、 IL Myeong Pharmaceutical Co., Ltd.、 Kolmar Korea、 Synmosa、 Itoh Kanpo Pharmaceutical Co., Ltd.、 Hanso Pharmaceutical、 Dr.Japan Co., Ltd.、 Guangdong Qingyunshan Pharmaceutical Co.,Ltd.、 Weidar Chemical & Pharmaceutical Co., Ltd.、 Tianjin Hezhi Pharmaceutical Group Co., Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、医薬品用OEM＆ODMのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の医薬品用OEM＆ODM市場：タイプ別、2018年-2023年、2024年-2029年
世界の医薬品用OEM＆ODM市場：タイプ別市場シェア、2022年
・医薬品OEM、医薬品ODM

世界の医薬品用OEM＆ODM市場：用途別、2018年-2023年、2024年-2029年
世界の医薬品用OEM＆ODM市場：用途別市場シェア、2022年
・漢方、西洋医学、生物学的製剤、その他

世界の医薬品用OEM＆ODM市場：地域・国別、2018年-2023年、2024年-2029年
世界の医薬品用OEM＆ODM市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における医薬品用OEM＆ODMのグローバル売上、2018年-2023年
・主要企業における医薬品用OEM＆ODMのグローバル売上シェア、2022年
・主要企業における医薬品用OEM＆ODMのグローバル販売量、2018年-2023年
・主要企業における医薬品用OEM＆ODMのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
JPS Pharmaceutical、 New-In CO., Ltd.、 Kosei Pharmaceutical Co., Ltd.、 CD Formulation、 DENKEN GROUP、 PIM Pharmaceuticals、 IL Myeong Pharmaceutical Co., Ltd.、 Kolmar Korea、 Synmosa、 Itoh Kanpo Pharmaceutical Co., Ltd.、 Hanso Pharmaceutical、 Dr.Japan Co., Ltd.、 Guangdong Qingyunshan Pharmaceutical Co.,Ltd.、 Weidar Chemical & Pharmaceutical Co., Ltd.、 Tianjin Hezhi Pharmaceutical Group Co., Ltd.

*************************************************************

・調査・分析レポートの概要
医薬品用OEM＆ODM市場の定義
市場セグメント
世界の医薬品用OEM＆ODM市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の医薬品用OEM＆ODM市場規模
世界の医薬品用OEM＆ODM市場規模：2022年 VS 2029年
世界の医薬品用OEM＆ODM市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの医薬品用OEM＆ODMの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の医薬品用OEM＆ODM製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：医薬品OEM、医薬品ODM
医薬品用OEM＆ODMのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：漢方、西洋医学、生物学的製剤、その他
医薬品用OEM＆ODMの用途別グローバル売上・予測

・地域別市場分析
地域別医薬品用OEM＆ODM市場規模 2022年と2029年
地域別医薬品用OEM＆ODM売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
JPS Pharmaceutical、 New-In CO., Ltd.、 Kosei Pharmaceutical Co., Ltd.、 CD Formulation、 DENKEN GROUP、 PIM Pharmaceuticals、 IL Myeong Pharmaceutical Co., Ltd.、 Kolmar Korea、 Synmosa、 Itoh Kanpo Pharmaceutical Co., Ltd.、 Hanso Pharmaceutical、 Dr.Japan Co., Ltd.、 Guangdong Qingyunshan Pharmaceutical Co.,Ltd.、 Weidar Chemical & Pharmaceutical Co., Ltd.、 Tianjin Hezhi Pharmaceutical Group Co., Ltd.
...

This research report provides a comprehensive analysis of the Pharmaceutical OEM and ODM market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Pharmaceutical OEM and ODM market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Pharmaceutical OEM and ODM, challenges faced by the industry, and potential opportunities for market players.
The global Pharmaceutical OEM and ODM market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Pharmaceutical OEM and ODM market presents opportunities for various stakeholders, including Traditional Chinese Medicine, Western Medicine. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Pharmaceutical OEM and ODM market. Additionally, the growing consumer demand present avenues for market expansion.
The global Pharmaceutical OEM and ODM market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Pharmaceutical OEM and ODM market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Pharmaceutical OEM and ODM market.
Market Overview: The report provides a comprehensive overview of the Pharmaceutical OEM and ODM market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Pharmaceutical OEM, Pharmaceutical ODM), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Pharmaceutical OEM and ODM market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Pharmaceutical OEM and ODM market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Pharmaceutical OEM and ODM market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Pharmaceutical OEM and ODM market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Pharmaceutical OEM and ODM market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Pharmaceutical OEM and ODM market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Pharmaceutical OEM and ODM, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Pharmaceutical OEM and ODM market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Pharmaceutical OEM and ODM market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Pharmaceutical OEM
Pharmaceutical ODM
Market segment by Application
Traditional Chinese Medicine
Western Medicine
Biologics
Others
Global Pharmaceutical OEM and ODM Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
JPS Pharmaceutical
New-In CO., Ltd.
Kosei Pharmaceutical Co., Ltd.
CD Formulation
DENKEN GROUP
PIM Pharmaceuticals
IL Myeong Pharmaceutical Co., Ltd.
Kolmar Korea
Synmosa
Itoh Kanpo Pharmaceutical Co., Ltd.
Hanso Pharmaceutical
Dr.Japan Co., Ltd.
Guangdong Qingyunshan Pharmaceutical Co.,Ltd.
Weidar Chemical & Pharmaceutical Co., Ltd.
Tianjin Hezhi Pharmaceutical Group Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical OEM and ODM, market overview.
Chapter 2: Global Pharmaceutical OEM and ODM market size in revenue.
Chapter 3: Detailed analysis of Pharmaceutical OEM and ODM company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical OEM and ODM in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical OEM and ODM Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical OEM and ODM Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical OEM and ODM Overall Market Size
2.1 Global Pharmaceutical OEM and ODM Market Size: 2022 VS 2029
2.2 Global Pharmaceutical OEM and ODM Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceutical OEM and ODM Players in Global Market
3.2 Top Global Pharmaceutical OEM and ODM Companies Ranked by Revenue
3.3 Global Pharmaceutical OEM and ODM Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical OEM and ODM Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pharmaceutical OEM and ODM Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical OEM and ODM Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutical OEM and ODM Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical OEM and ODM Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Pharmaceutical OEM and ODM Market Size Markets, 2022 & 2029
4.1.2 Pharmaceutical OEM
4.1.3 Pharmaceutical ODM
4.2 By Type – Global Pharmaceutical OEM and ODM Revenue & Forecasts
4.2.1 By Type – Global Pharmaceutical OEM and ODM Revenue, 2018-2023
4.2.2 By Type – Global Pharmaceutical OEM and ODM Revenue, 2024-2029
4.2.3 By Type – Global Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pharmaceutical OEM and ODM Market Size, 2022 & 2029
5.1.2 Traditional Chinese Medicine
5.1.3 Western Medicine
5.1.4 Biologics
5.1.5 Others
5.2 By Application – Global Pharmaceutical OEM and ODM Revenue & Forecasts
5.2.1 By Application – Global Pharmaceutical OEM and ODM Revenue, 2018-2023
5.2.2 By Application – Global Pharmaceutical OEM and ODM Revenue, 2024-2029
5.2.3 By Application – Global Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Pharmaceutical OEM and ODM Market Size, 2022 & 2029
6.2 By Region – Global Pharmaceutical OEM and ODM Revenue & Forecasts
6.2.1 By Region – Global Pharmaceutical OEM and ODM Revenue, 2018-2023
6.2.2 By Region – Global Pharmaceutical OEM and ODM Revenue, 2024-2029
6.2.3 By Region – Global Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Pharmaceutical OEM and ODM Revenue, 2018-2029
6.3.2 US Pharmaceutical OEM and ODM Market Size, 2018-2029
6.3.3 Canada Pharmaceutical OEM and ODM Market Size, 2018-2029
6.3.4 Mexico Pharmaceutical OEM and ODM Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Pharmaceutical OEM and ODM Revenue, 2018-2029
6.4.2 Germany Pharmaceutical OEM and ODM Market Size, 2018-2029
6.4.3 France Pharmaceutical OEM and ODM Market Size, 2018-2029
6.4.4 U.K. Pharmaceutical OEM and ODM Market Size, 2018-2029
6.4.5 Italy Pharmaceutical OEM and ODM Market Size, 2018-2029
6.4.6 Russia Pharmaceutical OEM and ODM Market Size, 2018-2029
6.4.7 Nordic Countries Pharmaceutical OEM and ODM Market Size, 2018-2029
6.4.8 Benelux Pharmaceutical OEM and ODM Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Pharmaceutical OEM and ODM Revenue, 2018-2029
6.5.2 China Pharmaceutical OEM and ODM Market Size, 2018-2029
6.5.3 Japan Pharmaceutical OEM and ODM Market Size, 2018-2029
6.5.4 South Korea Pharmaceutical OEM and ODM Market Size, 2018-2029
6.5.5 Southeast Asia Pharmaceutical OEM and ODM Market Size, 2018-2029
6.5.6 India Pharmaceutical OEM and ODM Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Pharmaceutical OEM and ODM Revenue, 2018-2029
6.6.2 Brazil Pharmaceutical OEM and ODM Market Size, 2018-2029
6.6.3 Argentina Pharmaceutical OEM and ODM Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Pharmaceutical OEM and ODM Revenue, 2018-2029
6.7.2 Turkey Pharmaceutical OEM and ODM Market Size, 2018-2029
6.7.3 Israel Pharmaceutical OEM and ODM Market Size, 2018-2029
6.7.4 Saudi Arabia Pharmaceutical OEM and ODM Market Size, 2018-2029
6.7.5 UAE Pharmaceutical OEM and ODM Market Size, 2018-2029
7 Pharmaceutical OEM and ODM Companies Profiles
7.1 JPS Pharmaceutical
7.1.1 JPS Pharmaceutical Company Summary
7.1.2 JPS Pharmaceutical Business Overview
7.1.3 JPS Pharmaceutical Pharmaceutical OEM and ODM Major Product Offerings
7.1.4 JPS Pharmaceutical Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.1.5 JPS Pharmaceutical Key News & Latest Developments
7.2 New-In CO., Ltd.
7.2.1 New-In CO., Ltd. Company Summary
7.2.2 New-In CO., Ltd. Business Overview
7.2.3 New-In CO., Ltd. Pharmaceutical OEM and ODM Major Product Offerings
7.2.4 New-In CO., Ltd. Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.2.5 New-In CO., Ltd. Key News & Latest Developments
7.3 Kosei Pharmaceutical Co., Ltd.
7.3.1 Kosei Pharmaceutical Co., Ltd. Company Summary
7.3.2 Kosei Pharmaceutical Co., Ltd. Business Overview
7.3.3 Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Major Product Offerings
7.3.4 Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.3.5 Kosei Pharmaceutical Co., Ltd. Key News & Latest Developments
7.4 CD Formulation
7.4.1 CD Formulation Company Summary
7.4.2 CD Formulation Business Overview
7.4.3 CD Formulation Pharmaceutical OEM and ODM Major Product Offerings
7.4.4 CD Formulation Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.4.5 CD Formulation Key News & Latest Developments
7.5 DENKEN GROUP
7.5.1 DENKEN GROUP Company Summary
7.5.2 DENKEN GROUP Business Overview
7.5.3 DENKEN GROUP Pharmaceutical OEM and ODM Major Product Offerings
7.5.4 DENKEN GROUP Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.5.5 DENKEN GROUP Key News & Latest Developments
7.6 PIM Pharmaceuticals
7.6.1 PIM Pharmaceuticals Company Summary
7.6.2 PIM Pharmaceuticals Business Overview
7.6.3 PIM Pharmaceuticals Pharmaceutical OEM and ODM Major Product Offerings
7.6.4 PIM Pharmaceuticals Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.6.5 PIM Pharmaceuticals Key News & Latest Developments
7.7 IL Myeong Pharmaceutical Co., Ltd.
7.7.1 IL Myeong Pharmaceutical Co., Ltd. Company Summary
7.7.2 IL Myeong Pharmaceutical Co., Ltd. Business Overview
7.7.3 IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Major Product Offerings
7.7.4 IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.7.5 IL Myeong Pharmaceutical Co., Ltd. Key News & Latest Developments
7.8 Kolmar Korea
7.8.1 Kolmar Korea Company Summary
7.8.2 Kolmar Korea Business Overview
7.8.3 Kolmar Korea Pharmaceutical OEM and ODM Major Product Offerings
7.8.4 Kolmar Korea Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.8.5 Kolmar Korea Key News & Latest Developments
7.9 Synmosa
7.9.1 Synmosa Company Summary
7.9.2 Synmosa Business Overview
7.9.3 Synmosa Pharmaceutical OEM and ODM Major Product Offerings
7.9.4 Synmosa Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.9.5 Synmosa Key News & Latest Developments
7.10 Itoh Kanpo Pharmaceutical Co., Ltd.
7.10.1 Itoh Kanpo Pharmaceutical Co., Ltd. Company Summary
7.10.2 Itoh Kanpo Pharmaceutical Co., Ltd. Business Overview
7.10.3 Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Major Product Offerings
7.10.4 Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.10.5 Itoh Kanpo Pharmaceutical Co., Ltd. Key News & Latest Developments
7.11 Hanso Pharmaceutical
7.11.1 Hanso Pharmaceutical Company Summary
7.11.2 Hanso Pharmaceutical Business Overview
7.11.3 Hanso Pharmaceutical Pharmaceutical OEM and ODM Major Product Offerings
7.11.4 Hanso Pharmaceutical Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.11.5 Hanso Pharmaceutical Key News & Latest Developments
7.12 Dr.Japan Co., Ltd.
7.12.1 Dr.Japan Co., Ltd. Company Summary
7.12.2 Dr.Japan Co., Ltd. Business Overview
7.12.3 Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Major Product Offerings
7.12.4 Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.12.5 Dr.Japan Co., Ltd. Key News & Latest Developments
7.13 Guangdong Qingyunshan Pharmaceutical Co.,Ltd.
7.13.1 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Company Summary
7.13.2 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Business Overview
7.13.3 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Major Product Offerings
7.13.4 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.13.5 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Key News & Latest Developments
7.14 Weidar Chemical & Pharmaceutical Co., Ltd.
7.14.1 Weidar Chemical & Pharmaceutical Co., Ltd. Company Summary
7.14.2 Weidar Chemical & Pharmaceutical Co., Ltd. Business Overview
7.14.3 Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Major Product Offerings
7.14.4 Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.14.5 Weidar Chemical & Pharmaceutical Co., Ltd. Key News & Latest Developments
7.15 Tianjin Hezhi Pharmaceutical Group Co., Ltd.
7.15.1 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Company Summary
7.15.2 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Business Overview
7.15.3 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Major Product Offerings
7.15.4 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Revenue in Global Market (2018-2023)
7.15.5 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Pharmaceutical OEM and ODM Market Opportunities & Trends in Global Market
Table 2. Pharmaceutical OEM and ODM Market Drivers in Global Market
Table 3. Pharmaceutical OEM and ODM Market Restraints in Global Market
Table 4. Key Players of Pharmaceutical OEM and ODM in Global Market
Table 5. Top Pharmaceutical OEM and ODM Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pharmaceutical OEM and ODM Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pharmaceutical OEM and ODM Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pharmaceutical OEM and ODM Product Type
Table 9. List of Global Tier 1 Pharmaceutical OEM and ODM Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceutical OEM and ODM Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pharmaceutical OEM and ODM Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pharmaceutical OEM and ODM Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pharmaceutical OEM and ODM Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pharmaceutical OEM and ODM Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pharmaceutical OEM and ODM Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pharmaceutical OEM and ODM Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2024-2029
Table 30. JPS Pharmaceutical Company Summary
Table 31. JPS Pharmaceutical Pharmaceutical OEM and ODM Product Offerings
Table 32. JPS Pharmaceutical Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 33. JPS Pharmaceutical Key News & Latest Developments
Table 34. New-In CO., Ltd. Company Summary
Table 35. New-In CO., Ltd. Pharmaceutical OEM and ODM Product Offerings
Table 36. New-In CO., Ltd. Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 37. New-In CO., Ltd. Key News & Latest Developments
Table 38. Kosei Pharmaceutical Co., Ltd. Company Summary
Table 39. Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product Offerings
Table 40. Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 41. Kosei Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 42. CD Formulation Company Summary
Table 43. CD Formulation Pharmaceutical OEM and ODM Product Offerings
Table 44. CD Formulation Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 45. CD Formulation Key News & Latest Developments
Table 46. DENKEN GROUP Company Summary
Table 47. DENKEN GROUP Pharmaceutical OEM and ODM Product Offerings
Table 48. DENKEN GROUP Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 49. DENKEN GROUP Key News & Latest Developments
Table 50. PIM Pharmaceuticals Company Summary
Table 51. PIM Pharmaceuticals Pharmaceutical OEM and ODM Product Offerings
Table 52. PIM Pharmaceuticals Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 53. PIM Pharmaceuticals Key News & Latest Developments
Table 54. IL Myeong Pharmaceutical Co., Ltd. Company Summary
Table 55. IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product Offerings
Table 56. IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 57. IL Myeong Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 58. Kolmar Korea Company Summary
Table 59. Kolmar Korea Pharmaceutical OEM and ODM Product Offerings
Table 60. Kolmar Korea Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 61. Kolmar Korea Key News & Latest Developments
Table 62. Synmosa Company Summary
Table 63. Synmosa Pharmaceutical OEM and ODM Product Offerings
Table 64. Synmosa Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 65. Synmosa Key News & Latest Developments
Table 66. Itoh Kanpo Pharmaceutical Co., Ltd. Company Summary
Table 67. Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product Offerings
Table 68. Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 69. Itoh Kanpo Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 70. Hanso Pharmaceutical Company Summary
Table 71. Hanso Pharmaceutical Pharmaceutical OEM and ODM Product Offerings
Table 72. Hanso Pharmaceutical Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 73. Hanso Pharmaceutical Key News & Latest Developments
Table 74. Dr.Japan Co., Ltd. Company Summary
Table 75. Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Product Offerings
Table 76. Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 77. Dr.Japan Co., Ltd. Key News & Latest Developments
Table 78. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Company Summary
Table 79. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Product Offerings
Table 80. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 81. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Key News & Latest Developments
Table 82. Weidar Chemical & Pharmaceutical Co., Ltd. Company Summary
Table 83. Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product Offerings
Table 84. Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 85. Weidar Chemical & Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 86. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Company Summary
Table 87. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Product Offerings
Table 88. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Revenue (US$, Mn) & (2018-2023)
Table 89. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Key News & Latest Developments
List of Figures
Figure 1. Pharmaceutical OEM and ODM Segment by Type in 2022
Figure 2. Pharmaceutical OEM and ODM Segment by Application in 2022
Figure 3. Global Pharmaceutical OEM and ODM Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pharmaceutical OEM and ODM Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pharmaceutical OEM and ODM Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceutical OEM and ODM Revenue in 2022
Figure 8. By Type - Global Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
Figure 16. US Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
Figure 20. Germany Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 21. France Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
Figure 28. China Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 32. India Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
Figure 34. Brazil Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pharmaceutical OEM and ODM Revenue Market Share, 2018-2029
Figure 37. Turkey Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pharmaceutical OEM and ODM Revenue, (US$, Mn), 2018-2029
Figure 41. JPS Pharmaceutical Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. New-In CO., Ltd. Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. CD Formulation Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. DENKEN GROUP Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. PIM Pharmaceuticals Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Kolmar Korea Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Synmosa Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hanso Pharmaceutical Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 化粧品OEM/ODMのグローバル市場展望 2023年-2029年：化粧品OEM、化粧品ODM
  • 医薬品用共同包装のグローバル市場展望 2023年-2029年：ペットボトル、ブリスターパック、ガラス容器、その他
  • 医薬品安定性試験チャンバーのグローバル市場展望 2023年-2029年：可動型安定性試験チャンバー、卓上型安定性試験チャンバー
  • 医薬品用プルランのグローバル市場展望 2023年-2029年：高純度プルラン、通常プルラン
  • 医薬品用発酵エンジニアリングのグローバル市場展望 2023年-2029年：モノクローナル抗体、抗生物質、インスリン、ヒト成長ホルモン、医薬品アミノ酸、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC16527 )"医薬品用OEM＆ODMのグローバル市場展望 2023年-2029年：医薬品OEM、医薬品ODM" (英文：Pharmaceutical OEM and ODM Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。